Cancer Registration: Kaplan-Meier survival estimates by FIGO stage for patients diagnosed with cervical cancer (ICD 10 C53)

Open data API in a single place

Provided by Public Health England

Get early access to Cancer Registration: Kaplan-Meier survival estimates by FIGO stage for patients diagnosed with cervical cancer (ICD 10 C53) API!

Let us know and we will figure it out for you.

Dataset information

Country of origin
Updated
Created
Available languages
English
Keywords
Quality scoring

Dataset description

National Cancer Registration and Analysis Service (NCRAS). (2018). Cancer Registration: Kaplan-Meier survival estimates by FIGO stage for patients diagnosed with cervical cancer (ICD 10 C53) [Data set]. Public Health England. https://doi.org/10.25503/52jw-9g78 Kaplan-Meier survival estimates and confidence intervals (at 1, 2, 3, 4 and 5 years after diagnosis) for patients diagnosed with cervical cancer (ICD 10 C53), between 01/01/2016 - 31/12/2016. The data is split into 5 cohorts; Groups 1, 2, 3 4 and 5 respectively. Each of these groups is defined below and survival estimates presented by FIGO stage. Frequency counts are presented for total count of patients by group, by FIGO stage. Group 1: Age >=20.0 to <24.5 and diagnosed between 1/1/2006 to 31/12/2016. Group 2: Age >=26.0 to <30.0 and diagnosed during 1/1/2006 - 31/8/2008; Age >=26.0 to <28.0 diagnosed during 1/7/2009 - 31/12/2016; Age >=28.0 to <29.0 diagnosed during 1/7/2009 - 31/12/2011; Age >=29.0 to <30.0 diagnosed during 1/7/2009 - 31/12/2016; Excluding Age >=26.0 to <30.0 and diagnosed during 1/9/2008 - 30/6/2009. Group 3: Age >=24.5 to <25.0 and diagnosed during 1/1/2013 - 31/12/2016; Age >=25.0 to <25.5 and diagnosed during 1/1/2009 - 31/12/2016; Age >=25.5 to <26.0 and diagnosed during 1/1/2010 - 31/12/2015. Group 4: Age >=24.5 to <25.0 and diagnosed during 1/1/2006 - 31/12/2012; Age >=25.0 to <25.5 and diagnosed during 1/1/2006 - 31/12/2008; Age >=25.5 to <26.0and diagnosed during 1/1/2006 -31/12/2009. Group 5: Age >=28.0 to <29.0 and diagnosed during 1/1/2012 - 31/12/2016. Exclusions applied ** Cases with Figo Stage I where no additional stage information was available to allow classification to either Stage IA or Stage IB. *** For cases with multiple cervical tumours survival time was calculated from the first diagnosis.
European data infrastructure with broad catalog discovery, free evaluation access and production-grade API options.
190K+
indexed dataset pages
32
countries and EU institutions
2019
API-first since
Free API quota
for evaluation and prototypes
SLA
history and push on production APIs
FAQ

Questions before production use

Practical answers on evaluation, licensing, freshness, versioning and support.

api.store is built and operated by Apitalks s.r.o. Company details and a direct contact path are linked in the footer for vendor checks and procurement review.
Yes. Selected APIs include a free API quota, so your team can validate coverage, freshness, response shape and workflow fit before asking for a production plan.
Often yes, but usage rights depend on the source license and dataset. We surface source, license and update metadata where available, and can help review terms before a production integration.
Maintained APIs include update metadata where available. For production integrations, we can add history, monitoring and push updates so changes are easier to detect and act on.
Production APIs can add SLA, stable identifiers, versioning support, history, push updates and direct support around the data your product or AI workflow depends on.

Didn't find the API you need?

Let us know and we will figure it out for you.

European data discovery with free evaluation access and production-grade API options.

Copyright © 2026. Made by Apitalks